Drug Screening Market Analysis and Forecast to 2031: By Products & Service (Drug Screening Product, Analytical Instruments, Rapid Testing Devices, Oral Fluid Testing Devices, Consumables, Drug Screening Service), Sample Type (Urine Samples, Breath Samples

Drug Screening Market Analysis and Forecast to 2031: By Products & Service (Drug Screening Product, Analytical Instruments, Rapid Testing Devices, Oral Fluid Testing Devices, Consumables, Drug Screening Service), Sample Type (Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, Others), End User (Drug Testing Laboratories, Workplaces, Criminal Justice & Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools & Colleges), and Region

The global drug screening market was valued at USD 5.6 billion in 2021 and it is expected to reach up to USD 25.3 billion by 2031, at a CAGR of 16.3% during the projection period.

Drug screening is the process of recognizing illicit and some recommended drugs in the blood, urine, and other biological samples. A drug screening process is also called the analysis and detection of performance-enhancing drugs consumed by professional athletes like steroids and HGH in order to improve stamina and performance at the time of the sport.

Some of the major illegal drugs include heroin, cannabis, cocaine, methamphetamines, methadone, and amphetamine. The rising incidence of such drugs consumptions across the world is the major concern being faced by many governments. For example, according to National Institute on Drug Abuse (NIDA), in 2010, an estimated 22.6 million of the population were illicit drug users in the U.S, which accounted for an estimated 8.9% of the total population of the country.

Global Drug Screening Market Scope and Report Structure

Market Trends and Drivers

The key factor boosting the growth of the market is growing drug and alcohol consumption. Drug abuse and alcohol consumption are increasing worldwide. According to the World Drug Report 2021, in 2019, an estimated 275 million people across the globe aged 15–64, or 1 in every 18 people in that age group, have used drugs at least once in the previous year. In the same year, drug use killed almost half a million people, while drug use disorders resulted in 18 million years of healthy life lost, mainly owing to opioids. Alcohol consumption has shown similar increases, with consequences witnessed in the growing incidence of impaired driving. The increasing consumption of illicit drugs & alcohol will further boost the development of drug screening products & services on the road, thereby driving the overall market growth.

Market Restraints and Challenges

The key factor hindering the growth of the market is the prohibition of workplace drug testing in some countries. Some countries like Canada, Colombia, Argentina, Chile, and South Africa, consider drug & alcohol testing at the workplace to be a violation of employee privacy. For example, pre-employment drug testing is only performed in France when physicians recommend the test. In Poland and the Czech Republic, drug & alcohol tests in the workplace are prohibited. In Canada, the Eastern Canadian case laws permit drug & alcohol testing only when workplace operations are fundamentally dangerous or where drug and alcohol testing is limited to a few special cases. Such prohibitions in various countries may hamper the adoption of drug & alcohol testing in these markets, so restraining overall market growth to a certain extent.

Global Drug Screening Market Segmental Overview

The report analyses the global drug screening market based on the products & services, sample type, end users, and regions.

Global Drug Screening Market by Products & Services

Based on products & services, it is segmented into drug screening products, analytical instruments, rapid testing devices, oral fluid testing devices, oral fluid testing devices, consumables, and drug screening services. The drug screening products segment is likely to dominate the market during the forecast period. The growing drug and alcohol consumption coupled with the enforcement of stringent laws mandating drug & alcohol testing is boosting the growth of the market.

Global Drug Screening Market by Sample Type

Based on sample type, it is segmented into urine samples, breath samples, oral fluid samples, hair samples, and others. The urine samples segment is likely to dominate the market during the forecast period. The key factors attributing to the growth of the market are the enforcement of stringent law mandating drug & alcohol testing, rising regulatory approvals for drug screening products & services are boosting the growth of the market.

Global Drug Screening Market by End Users

Based on end users, it is segmented into drug testing laboratories, workplaces, criminal justice & law enforcement agencies, hospitals, drug treatment centers, individual users, pain management centers, school & colleges. The drug testing laboratories segment is likely to boost the market growth during the forecast period. The key factors boosting the growth of the market are stringent regulations by government agencies mandating alcohol and drug testing for safety purposes and increasing initiatives to monitor and combat substance abuse are likely to boost the growth of the market.

Geographical Analysis of Global Drug Screening Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The North American region is likely to dominate the market during the forecast period. The key factor attributed to the growth of the market is the growing consumption of illicit drugs, the availability of government funding to curb abuse, laws supporting drug screening, the growing burden of accidents owing to alcohol impairment, and the presence of key players in the region are boosting the growth of the market.

Major Players in the Global Drug Screening Market

Recent Developments

• August 2021, Quest Diagnostics and Select Health of South Carolina entered into an agreement to expand Select Health’s laboratory network for its Medicaid and Medicare-Medicaid dual-eligible enrollees and to enhance access to diagnostics information services for members.
• September 2020, Lab Corp entered into a multi-year agreement with Infirmary Health to offer laboratory testing services in the Eastern Gulf Coast.
• May 2020, Psychemedics introduced a vaping panel test that detects the ingestion of marijuana, CBD, and nicotine drugs by all methods, comprising electronic cigarettes or smoking.
• April 2019, Thermo Fisher Scientific introduced CEDIA Mitragynine Assay for the detection of Kratom for criminal justice and forensic use only.
• May 2018, Omega Laboratories introduced the Omega Hair 17 panel drug test capable of detecting 45 different substances, comprising eight commonly abused variants of benzodiazepines.

Frequently Asked QuestionsQ1. How big is the Drug Screening market?Ans. The global Drug Screening market size was USD 5.6 Billion in 2021 and is anticipated to reach USD 25.3 Billion in 2031, growing at a rate of 16.3% from 2022 to 2031.Q2. What is the Drug Screening market growth rate?Ans. The growth rate of the Drug Screening market is 16.3% from 2022 to 2031.Q3. Which region holds a major market share for the Drug Screening market?Ans. North America holds a major market share of the Drug Screening market in 2021.Q4. Which segment accounted for the largest Drug Screening market share?Ans. By end user, the drug testing laboratories segment accounted for the largest Drug Screening market share.Q5. Who are the key players in the Drug Screening market?Q6. What are the factors driving the Drug Screening market growth?Ans. The major factors driving the growth of the market are growing drug and alcohol consumption.Q7. What are the key growth strategies of Drug Screening market players?Ans. The key growth strategies of Drug Screening market players are product launch and product approval.Q8. Which region will provide more business opportunities for the Drug Screening market during the forecast period?Ans. The Asia-Pacific region will provide more business opportunities for the Drug Screening market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.